Researchers at Ulm University Hospital discovered that mutations in the brain’s MC4R gene, which cause obesity, also lower ...

If you have experience with R or want a quick way to generate a regression with statsmodels using a pandas DataFrame, you can ...

For decades, Paranthropus robustus has intrigued scientists as a powerful, big-jawed cousin of early humans. Now, thanks to ancient protein analysis, researchers have cracked open new secrets hidden ...

The DESTINY-Breast11 trial showed in patients with high-risk HER2-positive early breast cancer that the ADC followed by ...

Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...

For the three months ended September 30, 2025, Syndax reported a net loss attributable to common stockholders of $60.7 million, or $0.70 per share, compared to a net loss attributable to common ...

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ('SELLAS’’ or the 'Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...

Q1 2026 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...